B3AR Therapeutics, Inc.
Records under this name other than the patents B3AR Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.
Showing 1 to 7 of 7 · Back to B3AR Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,691,944 | Solabegron Zwitterion and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,435,026 | Solabegron Zwitterion and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,065,922 | Solabegron Zwitterion and Uses Thereof Lapsed on the fee record Ended Sep 4, 2026 · High confidence | Lapsed on the fee record | Ended Sep 4, 2026 | High confidence |
| US 7,425,639 | Process Term ended Term ended Dec 26, 2023 · High confidence | Term ended | Term ended Dec 26, 2023 | High confidence |
| US 7,034,053 | Phenethanolamine Derivatives, Compositions, and Their Use as Agonists at Atypical Beta-Adrenoreceptors Term ended Term ended Sep 3, 2022 · High confidence | Term ended | Term ended Sep 3, 2022 | High confidence |
| US 7,709,677 | Process of Preparing Arylethanoldiamines Term ended Term ended Dec 17, 2021 · High confidence | Term ended | Term ended Dec 17, 2021 | High confidence |
| US 6,548,523 | Process for the Preparation of Arylethanolamine Derivatives Having an Anti-Obesity and Anti-Diabetic Properties Term ended Term ended Dec 8, 2020 · High confidence | Term ended | Term ended Dec 8, 2020 | High confidence |